Pregled bibliografske jedinice broj: 1046251
Metotreksat – zlatni standard u reumatologiji
Metotreksat – zlatni standard u reumatologiji // Medicus, 27 (2018), 1 Debljina i ...; 95-100 (recenziran, pregledni rad, ostalo)
CROSBI ID: 1046251 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Metotreksat – zlatni standard u reumatologiji
(Metotreksat – gold standard in rheumatology)
Autori
Žagar, Iva
Izvornik
Medicus (1330-013X) 27
(2018), 1 Debljina i ...;
95-100
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, ostalo
Ključne riječi
metotreksat ; reumatoidni artritis ; psorijatični artritis
Sažetak
Methotrexate (MTX) is a structural analogue of folic acid which is used primarily to treat inMammatory rheumatic diseases, with oral or parenteral administration. The efficacy of MTX in the treatment of rheumatoid arthritis has been demonstrated in several randomized clinical studies and conformed in meta-analyses. Today, MTX represents the golden standard for the treatment of rheumatoid arthritis. The treatment starts at doses between 7.5 and 15 mg per week, with possible dose escalation based on disease activity. Careful patient monitoring reduces the risk of hepatotoxicity and other adverse effects, making MTX the drug of first choice for the treatment of rheumatoid and psoriatic arthritis.
Izvorni jezik
Hrvatski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Iva Žagar
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
